Aquestive Therapeutics, Inc. AQST Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestPayableCurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s accrued interest?
- Aquestive Therapeutics, Inc. (AQST) reported accrued interest of $17K in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s accrued interest changed year-over-year?
- Aquestive Therapeutics, Inc.'s accrued interest decreased by 0.0% year-over-year, from $17K to $17K.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s accrued interest?
- Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s accrued interest has grown at a -87.0% compound annual growth rate (CAGR), from $1.01M to $17K.
- What does accrued interest mean?
- Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.